United Kingdom · Question · Written question
HL HL6785
Drugs: Artificial Intelligence
Introduced
23 April 2025
Last action
1 May 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Artificial intelligence
Source updated
1 May 2025
Summary
To ask His Majesty's Government what assessment they have made of the use of AI-integrated health monitoring tools to manage unsupervised use of medications such as semaglutide.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 April 2025
Written question
To ask His Majesty's Government what assessment they have made of the use of AI-integrated health monitoring tools to manage unsupervised use of medications such as semaglutide.
Source: Lords
1 May 2025
Answer
Currently, no assessment has been made on the use of artificial intelligence (AI) to monitor the unsupervised use of these medications. However, we recognise the potential of AI and monitoring systems to support people’s health and care, including through...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-04-23/HL6785
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1796544
- uk · wq-1796544 · source updated 1 May 2025